Exclusive contract for ViroCAP® My Plasma with Landsberg First Class Aesthetic opens up Viromed's entry into the European cosmetics market  Pinneberg, April 25, 2025 - Viromed Medical AG ("Viromed", Ticker: VMED; ISIN: DE000A3MQR65), a medical device company and pioneer in cold plasma technology, and Landsberg First Class Aesthetic ("Landsberg"),  [ … ]

Viromed Medical AG welcomes Dr. Thomas Gutschlag as new Investor  Pinneberg, April 23, 2025 - Viromed Medical AG ("Viromed", ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in wound healing, intensive care medicine and air disinfection, has gained Dr. Thomas Gutschlag, founder  [ … ]

Viromed Medical AG: Exclusive distribution partnership with AMAMUS Vet for the cold plasma medical device ViroCAP® VET for veterinary use  Pinneberg, April 10. April 2025 - Viromed Medical AG ("Viromed", ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in wound healing, intensiv [ … ]

Viromed Medical AG: UMECO Group acquires exclusive marketing rights in Asia for cold plasma medical devices ViroCAP® and PulmoPlas®   Pinneberg, 01. April 2025 - Viromed Medical AG ("Viromed", ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in air disinfection, wound healing an [ … ]

Viromed Medical AG reports promising study results for PulmoPlas® in intensive care unit ventilator-associated pneumonia patients Pinneberg, Germany, March 14, 2025 - Viromed Medical AG (“Viromed”, Ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in room air sterilization, woun [ … ]

Viromed Medical AG: Strategic healthcare investor acquires further shares in private placement Pinneberg, 7 March 2025 – Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) has been informed by its majority shareholder (together with his wife) and CEO Uwe Perbandt about a further off-market placement of a total of 900,000 shares from his holdings [ … ]

Viromed Medical AG reaches milestone for cooperation with multinational corporation Pinneberg, 28 February 2025 –Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) has reached a milestone in the extensive cooperation with a multinational corporation announced via ad hoc notification on 11 December 2024. The subject of the agreement now concluded [ … ]

Viromed Medical AG: Successful placement of shares with a strategic investor in the healthcare industry to accelerate market entry in Europe Pinneberg, 5 February 2025 –Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) was informed by its majority shareholder (together with his wife) and CEO Uwe Perbandt about the off-market placement of a tot [ … ]